orexin a (human, rat, mouse) Search Results


orexin a  (Tocris)
93
Tocris orexin a
Orexin A, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/orexin+a+%28human%2C+rat%2C+mouse%29/pmc05535327-37-0-7?v=Tocris
Average 93 stars, based on 1 article reviews
orexin a - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
orexin a  (MedChemExpress)
93
MedChemExpress orexin a
tDCS promotes the expression of OXA and OX1R in TBI rats. ( A ) Representative western blotting images <t>of</t> <t>Orexin-A</t> and Orexin-A receptor 1 (OX1R) on 14 days post-TBI. Using GAPDH as an internal reference for band density normalization ( n = 3). ( B ) Quantification of western blotting for Orexin-A expression ( n = 3). ( C ) Quantification of western blotting for OX1R expression ( n = 3). ( D ) Representative immunofluorescence images of OX1R expression in brain tissue ( n = 3). ( E ) Quantification of immunofluorescence for OX1R expression ( n = 3). ( F ) Quantitative analysis of mRNA levels of OX1R expression ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * represents the comparison between the Sham group and the TBI group, # signifies the comparison between the TBI group and the tDCS group, and & denotes the comparison between the tDCS group and the Sham-tDCS group. P < 0.05 indicates statistical significance.
Orexin A, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/orexin+a+%28human%2C+rat%2C+mouse%29/pmc11042948-154-7-8?v=MedChemExpress
Average 93 stars, based on 1 article reviews
orexin a - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
oxa  (MedChemExpress)
94
MedChemExpress oxa
tDCS promotes the expression of OXA and OX1R in TBI rats. ( A ) Representative western blotting images <t>of</t> <t>Orexin-A</t> and Orexin-A receptor 1 (OX1R) on 14 days post-TBI. Using GAPDH as an internal reference for band density normalization ( n = 3). ( B ) Quantification of western blotting for Orexin-A expression ( n = 3). ( C ) Quantification of western blotting for OX1R expression ( n = 3). ( D ) Representative immunofluorescence images of OX1R expression in brain tissue ( n = 3). ( E ) Quantification of immunofluorescence for OX1R expression ( n = 3). ( F ) Quantitative analysis of mRNA levels of OX1R expression ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * represents the comparison between the Sham group and the TBI group, # signifies the comparison between the TBI group and the tDCS group, and & denotes the comparison between the tDCS group and the Sham-tDCS group. P < 0.05 indicates statistical significance.
Oxa, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/orexin+a+%28human%2C+rat%2C+mouse%29/10__4103_slash_nrr__nrr___d___24___01153-169-5-6?v=MedChemExpress
Average 94 stars, based on 1 article reviews
oxa - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
human rat thermo  (Thermo Fisher)
94
Thermo Fisher human rat thermo
tDCS promotes the expression of OXA and OX1R in TBI rats. ( A ) Representative western blotting images <t>of</t> <t>Orexin-A</t> and Orexin-A receptor 1 (OX1R) on 14 days post-TBI. Using GAPDH as an internal reference for band density normalization ( n = 3). ( B ) Quantification of western blotting for Orexin-A expression ( n = 3). ( C ) Quantification of western blotting for OX1R expression ( n = 3). ( D ) Representative immunofluorescence images of OX1R expression in brain tissue ( n = 3). ( E ) Quantification of immunofluorescence for OX1R expression ( n = 3). ( F ) Quantitative analysis of mRNA levels of OX1R expression ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * represents the comparison between the Sham group and the TBI group, # signifies the comparison between the TBI group and the tDCS group, and & denotes the comparison between the tDCS group and the Sham-tDCS group. P < 0.05 indicates statistical significance.
Human Rat Thermo, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/orexin+a+%28human%2C+rat%2C+mouse%29/us10077446-605-19-20?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
human rat thermo - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
orexin rescue  (MedChemExpress)
94
MedChemExpress orexin rescue
tDCS promotes the expression of OXA and OX1R in TBI rats. ( A ) Representative western blotting images <t>of</t> <t>Orexin-A</t> and Orexin-A receptor 1 (OX1R) on 14 days post-TBI. Using GAPDH as an internal reference for band density normalization ( n = 3). ( B ) Quantification of western blotting for Orexin-A expression ( n = 3). ( C ) Quantification of western blotting for OX1R expression ( n = 3). ( D ) Representative immunofluorescence images of OX1R expression in brain tissue ( n = 3). ( E ) Quantification of immunofluorescence for OX1R expression ( n = 3). ( F ) Quantitative analysis of mRNA levels of OX1R expression ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * represents the comparison between the Sham group and the TBI group, # signifies the comparison between the TBI group and the tDCS group, and & denotes the comparison between the tDCS group and the Sham-tDCS group. P < 0.05 indicates statistical significance.
Orexin Rescue, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/orexin+a+%28human%2C+rat%2C+mouse%29/bio_rxiv__64898__2026__01__22__701182-182-1-8?v=MedChemExpress
Average 94 stars, based on 1 article reviews
orexin rescue - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
orexin a human, rat, mouse  (Bachem)
90
Bachem orexin a human, rat, mouse
tDCS promotes the expression of OXA and OX1R in TBI rats. ( A ) Representative western blotting images <t>of</t> <t>Orexin-A</t> and Orexin-A receptor 1 (OX1R) on 14 days post-TBI. Using GAPDH as an internal reference for band density normalization ( n = 3). ( B ) Quantification of western blotting for Orexin-A expression ( n = 3). ( C ) Quantification of western blotting for OX1R expression ( n = 3). ( D ) Representative immunofluorescence images of OX1R expression in brain tissue ( n = 3). ( E ) Quantification of immunofluorescence for OX1R expression ( n = 3). ( F ) Quantitative analysis of mRNA levels of OX1R expression ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * represents the comparison between the Sham group and the TBI group, # signifies the comparison between the TBI group and the tDCS group, and & denotes the comparison between the tDCS group and the Sham-tDCS group. P < 0.05 indicates statistical significance.
Orexin A Human, Rat, Mouse, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/orexin+a+%28human%2C+rat%2C+mouse%29/10__3390_slash_molecules23112926-212-15-17?v=Bachem
Average 90 stars, based on 1 article reviews
orexin a human, rat, mouse - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
ria kit orexin a (human, rat, mouse, porcine, ovine, bovine, monkey)  (PHOENIX Group)
90
PHOENIX Group ria kit orexin a (human, rat, mouse, porcine, ovine, bovine, monkey)
tDCS promotes the expression of OXA and OX1R in TBI rats. ( A ) Representative western blotting images <t>of</t> <t>Orexin-A</t> and Orexin-A receptor 1 (OX1R) on 14 days post-TBI. Using GAPDH as an internal reference for band density normalization ( n = 3). ( B ) Quantification of western blotting for Orexin-A expression ( n = 3). ( C ) Quantification of western blotting for OX1R expression ( n = 3). ( D ) Representative immunofluorescence images of OX1R expression in brain tissue ( n = 3). ( E ) Quantification of immunofluorescence for OX1R expression ( n = 3). ( F ) Quantitative analysis of mRNA levels of OX1R expression ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * represents the comparison between the Sham group and the TBI group, # signifies the comparison between the TBI group and the tDCS group, and & denotes the comparison between the tDCS group and the Sham-tDCS group. P < 0.05 indicates statistical significance.
Ria Kit Orexin A (Human, Rat, Mouse, Porcine, Ovine, Bovine, Monkey), supplied by PHOENIX Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/orexin+a+%28human%2C+rat%2C+mouse%29/pm40250157-50-12-16?v=PHOENIX+Group
Average 90 stars, based on 1 article reviews
ria kit orexin a (human, rat, mouse, porcine, ovine, bovine, monkey) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
orexin a human, rat, mouse  (Biosynth Carbosynth)
N/A
   Buy from Supplier
orexin a bovine human mouse rat  (Elabscience)
N/A
   Buy from Supplier
orexin a (human, rat, mouse) (tfa)  (Aladdin Scientific Corporation)
N/A
Orexin A (human, rat, mouse) (Hypocretin-1 (human, rat, mouse)) TFA, a 33 amino acid excitatory neuropeptide, orchestrates diverse central and peripheral processes. Orexin A (human, rat, mouse) TFA is a specific, high-affinity agonist for G-protein-coupleAppearance:SolidIC50&
   Buy from Supplier
orexin a human, rat, mouse  (Aladdin Scientific Corporation)
N/A
Product Describtion:Orexins (hypocretins) comprise a family of hypothalamic peptides that are involved in the initiation of sleep and in feeding behavior. Orexin A stimulates food intake through activation of the OX1 receptor. Orexin B activates
   Buy from Supplier

Image Search Results


tDCS promotes the expression of OXA and OX1R in TBI rats. ( A ) Representative western blotting images of Orexin-A and Orexin-A receptor 1 (OX1R) on 14 days post-TBI. Using GAPDH as an internal reference for band density normalization ( n = 3). ( B ) Quantification of western blotting for Orexin-A expression ( n = 3). ( C ) Quantification of western blotting for OX1R expression ( n = 3). ( D ) Representative immunofluorescence images of OX1R expression in brain tissue ( n = 3). ( E ) Quantification of immunofluorescence for OX1R expression ( n = 3). ( F ) Quantitative analysis of mRNA levels of OX1R expression ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * represents the comparison between the Sham group and the TBI group, # signifies the comparison between the TBI group and the tDCS group, and & denotes the comparison between the tDCS group and the Sham-tDCS group. P < 0.05 indicates statistical significance.

Journal: Aging (Albany NY)

Article Title: Transcranial direct current stimulation promotes angiogenesis and improves neurological function via the OXA-TF-AKT/ERK signaling pathway in traumatic brain injury

doi: 10.18632/aging.205724

Figure Lengend Snippet: tDCS promotes the expression of OXA and OX1R in TBI rats. ( A ) Representative western blotting images of Orexin-A and Orexin-A receptor 1 (OX1R) on 14 days post-TBI. Using GAPDH as an internal reference for band density normalization ( n = 3). ( B ) Quantification of western blotting for Orexin-A expression ( n = 3). ( C ) Quantification of western blotting for OX1R expression ( n = 3). ( D ) Representative immunofluorescence images of OX1R expression in brain tissue ( n = 3). ( E ) Quantification of immunofluorescence for OX1R expression ( n = 3). ( F ) Quantitative analysis of mRNA levels of OX1R expression ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * represents the comparison between the Sham group and the TBI group, # signifies the comparison between the TBI group and the tDCS group, and & denotes the comparison between the tDCS group and the Sham-tDCS group. P < 0.05 indicates statistical significance.

Article Snippet: In order to investigate the influence of Orexin-A (MedChemExpress, USA, HY-106224) on TNF-α (Abbkine, USA, PRP1013)-induced HUVEC cells and explore potential mechanisms, we subjected the cells to varying concentrations of Orexin-A (0.1, 0.5, and 1 μM), TNF-α (10 ng/mL), and the inhibitor LY3214996 (MedChemExpress, HY-101494) of the ERK1/2 signal transduction pathway (1 μM).

Techniques: Expressing, Western Blot, Immunofluorescence, Standard Deviation, Comparison

Orexin-A improved scratch wound healing and angiogenesis of TNF-α-injured HUVEC cells. ( A ) The image shows the effect of Orexin-A (TO1: 0.1 μM, TO2: 0.5 μM and TO3: 1 μM) on wound healing of TNF-α (10 ng/ml) injured cells. ( B ) Quantification of Orexin-A on wound closure ( n = 3). ( C ) Representative images of the study effects of TNF-α (10 ng/ml) and the three concentrations (TO1: 0.1, TO2: 0.5 and TO3: 1 μM) of Orexin-A on tube formation. ( D ) Quantification of the effects of Orexin-A on the number of capillary-like tubes in TNF-α-treated cells ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * denotes the comparison between the Sham group and the TBI group, # represents the comparison between the TBI and the Sham-tDCS group, & signifies the comparison between the tDCS group and the Sham-tDCS group, and ¥ indicates the comparison between the tDCS group and the tDCS+SB334867 group. P < 0.05 indicates statistical significance.

Journal: Aging (Albany NY)

Article Title: Transcranial direct current stimulation promotes angiogenesis and improves neurological function via the OXA-TF-AKT/ERK signaling pathway in traumatic brain injury

doi: 10.18632/aging.205724

Figure Lengend Snippet: Orexin-A improved scratch wound healing and angiogenesis of TNF-α-injured HUVEC cells. ( A ) The image shows the effect of Orexin-A (TO1: 0.1 μM, TO2: 0.5 μM and TO3: 1 μM) on wound healing of TNF-α (10 ng/ml) injured cells. ( B ) Quantification of Orexin-A on wound closure ( n = 3). ( C ) Representative images of the study effects of TNF-α (10 ng/ml) and the three concentrations (TO1: 0.1, TO2: 0.5 and TO3: 1 μM) of Orexin-A on tube formation. ( D ) Quantification of the effects of Orexin-A on the number of capillary-like tubes in TNF-α-treated cells ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * denotes the comparison between the Sham group and the TBI group, # represents the comparison between the TBI and the Sham-tDCS group, & signifies the comparison between the tDCS group and the Sham-tDCS group, and ¥ indicates the comparison between the tDCS group and the tDCS+SB334867 group. P < 0.05 indicates statistical significance.

Article Snippet: In order to investigate the influence of Orexin-A (MedChemExpress, USA, HY-106224) on TNF-α (Abbkine, USA, PRP1013)-induced HUVEC cells and explore potential mechanisms, we subjected the cells to varying concentrations of Orexin-A (0.1, 0.5, and 1 μM), TNF-α (10 ng/mL), and the inhibitor LY3214996 (MedChemExpress, HY-101494) of the ERK1/2 signal transduction pathway (1 μM).

Techniques: Standard Deviation, Comparison

Orexin-A enhanced HUVEC angiogenesis and wound healing through TF-AKT/ERK pathway. ( A ) Representative images depicting the combined administration of LY3214996 (1 μM) and Orexin-A (0.5 μM) on wound healing effects. ( B ) The quantification of scratch assay results for each group is shown, measuring the closure of scratch gaps ( n = 3). ( C ) Representative images illustrating the impact of the combined administration of LY3214996 (1 μM) and Orexin-A (0.5 μM) on vascular formation. ( D ) Displays the quantification of tube formation assay results for each group, calculating the number of formed tubes ( n = 3). ( E ) Representative gross morphology of Matrigel in situ ( n = 3). ( F ) Representative H&E-stained images of matrix plug sections ( n =3). ( G ) Representative immunofluorescence images of CD31-positive cells within matrix plugs. ( H ) Quantitative analysis of the proportion of CD31-positive cells within matrix plugs ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * denotes the comparison between the Sham group and the TBI group, # represents the comparison between the TBI and the Sham-tDCS group, & signifies the comparison between the tDCS group and the Sham-tDCS group, and ¥ indicates the comparison between the tDCS group and the tDCS+SB334867 group. P < 0.05 indicates statistical significance.

Journal: Aging (Albany NY)

Article Title: Transcranial direct current stimulation promotes angiogenesis and improves neurological function via the OXA-TF-AKT/ERK signaling pathway in traumatic brain injury

doi: 10.18632/aging.205724

Figure Lengend Snippet: Orexin-A enhanced HUVEC angiogenesis and wound healing through TF-AKT/ERK pathway. ( A ) Representative images depicting the combined administration of LY3214996 (1 μM) and Orexin-A (0.5 μM) on wound healing effects. ( B ) The quantification of scratch assay results for each group is shown, measuring the closure of scratch gaps ( n = 3). ( C ) Representative images illustrating the impact of the combined administration of LY3214996 (1 μM) and Orexin-A (0.5 μM) on vascular formation. ( D ) Displays the quantification of tube formation assay results for each group, calculating the number of formed tubes ( n = 3). ( E ) Representative gross morphology of Matrigel in situ ( n = 3). ( F ) Representative H&E-stained images of matrix plug sections ( n =3). ( G ) Representative immunofluorescence images of CD31-positive cells within matrix plugs. ( H ) Quantitative analysis of the proportion of CD31-positive cells within matrix plugs ( n = 3). Results are expressed as means ± standard deviation, the statistical significance of differences was evaluated by One-way ANOVA, * denotes the comparison between the Sham group and the TBI group, # represents the comparison between the TBI and the Sham-tDCS group, & signifies the comparison between the tDCS group and the Sham-tDCS group, and ¥ indicates the comparison between the tDCS group and the tDCS+SB334867 group. P < 0.05 indicates statistical significance.

Article Snippet: In order to investigate the influence of Orexin-A (MedChemExpress, USA, HY-106224) on TNF-α (Abbkine, USA, PRP1013)-induced HUVEC cells and explore potential mechanisms, we subjected the cells to varying concentrations of Orexin-A (0.1, 0.5, and 1 μM), TNF-α (10 ng/mL), and the inhibitor LY3214996 (MedChemExpress, HY-101494) of the ERK1/2 signal transduction pathway (1 μM).

Techniques: Wound Healing Assay, Tube Formation Assay, In Situ, Staining, Immunofluorescence, Standard Deviation, Comparison